| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| D A Wirshing, W C Wirshing, L Kysar, M A Berisford, D Goldstein, J Pashdag, J Mintz, S R Marde. Novel antipsychotics: comparison of weight gain liabilities. The Journal of clinical psychiatry. vol 60. issue 6. 1999-07-13. PMID:10401912. |
we performed a retrospective analysis of 122 clinical records of 92 male patients with dsm-iii-r schizophrenia to examine the relative weight gain liabilities of clozapine, risperidone, olanzapine, and sertindole compared with haloperidol. |
1999-07-13 |
2023-08-12 |
Not clear |
| L de Haan, D H Linszen, R Gorsir. Clozapine and obsessions in patients with recent-onset schizophrenia and other psychotic disorders. The Journal of clinical psychiatry. vol 60. issue 6. 1999-07-13. PMID:10401913. |
clozapine and obsessions in patients with recent-onset schizophrenia and other psychotic disorders. |
1999-07-13 |
2023-08-12 |
Not clear |
| L de Haan, D H Linszen, R Gorsir. Clozapine and obsessions in patients with recent-onset schizophrenia and other psychotic disorders. The Journal of clinical psychiatry. vol 60. issue 6. 1999-07-13. PMID:10401913. |
the increase or emergence of obsessions was compared in young patients with recent-onset schizophrenia or other psychotic disorders taking clozapine and other antipsychotic drugs. |
1999-07-13 |
2023-08-12 |
Not clear |
| N Bergemann, C Ehrig, K Diebold, C Mundt, R von Einsiede. Asymptomatic pancreatitis associated with clozapine. Pharmacopsychiatry. vol 32. issue 2. 1999-07-09. PMID:10333168. |
we report a case of asymptomatic pancreatitis subsequent to clozapine treatment at therapeutic doses in a 38-year-old male patient with chronic paranoid-hallucinatory schizophrenia. |
1999-07-09 |
2023-08-12 |
Not clear |
| H Hippiu. A historical perspective of clozapine. The Journal of clinical psychiatry. vol 60 Suppl 12. 1999-06-24. PMID:10372606. |
having challenged the established view that extrapyramidal symptoms are an intrinsic feature of antipsychotic activity, clozapine was developed as the first atypical antipsychotic with activity against both the positive and negative symptoms of schizophrenia. |
1999-06-24 |
2023-08-12 |
Not clear |
| H Hippiu. A historical perspective of clozapine. The Journal of clinical psychiatry. vol 60 Suppl 12. 1999-06-24. PMID:10372606. |
this article outlines the history of clozapine's development, from its discovery in 1958 to its current position as the "gold standard" therapy for treatment-resistant schizophrenia. |
1999-06-24 |
2023-08-12 |
Not clear |
| S R McGur. The effects of clozapine on cognitive functioning in schizophrenia. The Journal of clinical psychiatry. vol 60 Suppl 12. 1999-06-24. PMID:10372607. |
the effects of clozapine on cognitive functioning in schizophrenia. |
1999-06-24 |
2023-08-12 |
Not clear |
| S R McGur. The effects of clozapine on cognitive functioning in schizophrenia. The Journal of clinical psychiatry. vol 60 Suppl 12. 1999-06-24. PMID:10372607. |
however, there is evidence that the atypical antipsychotic clozapine may improve this core deficit of schizophrenia. |
1999-06-24 |
2023-08-12 |
Not clear |
| S R McGur. The effects of clozapine on cognitive functioning in schizophrenia. The Journal of clinical psychiatry. vol 60 Suppl 12. 1999-06-24. PMID:10372607. |
such cognitive improvements with clozapine treatment may offer an advantage to patients with schizophrenia by enhancing the possibility of better vocational functioning and quality of life. |
1999-06-24 |
2023-08-12 |
Not clear |
| L D Alphs, R Anan. Clozapine: the commitment to patient safety. The Journal of clinical psychiatry. vol 60 Suppl 12. 1999-06-24. PMID:10372610. |
clozapine represents the "gold standard" therapy for treatment-resistant schizophrenia including use for symptom reduction and use in patients intolerant of extrapyramidal side effects associated with other antipsychotics. |
1999-06-24 |
2023-08-12 |
Not clear |
| J Volavk. The effects of clozapine on aggression and substance abuse in schizophrenic patients. The Journal of clinical psychiatry. vol 60 Suppl 12. 1999-06-24. PMID:10372611. |
after 6 months of treatment with clozapine, substance abusers and nonabusers with schizophrenia or schizoaffective disorder showed similar improvements on measures of psychopathology and psychosocial functioning. |
1999-06-24 |
2023-08-12 |
Not clear |
| H Y Meltze. Suicide and schizophrenia: clozapine and the InterSePT study. International Clozaril/Leponex Suicide Prevention Trial. The Journal of clinical psychiatry. vol 60 Suppl 12. 1999-06-24. PMID:10372612. |
suicide and schizophrenia: clozapine and the intersept study. |
1999-06-24 |
2023-08-12 |
Not clear |
| M Campbell, P I Young, D N Bateman, J M Smith, S H Thoma. The use of atypical antipsychotics in the management of schizophrenia. British journal of clinical pharmacology. vol 47. issue 1. 1999-06-18. PMID:10073734. |
most published evidence exists to support the use of clozapine, which has also been shown to be effective in schizophrenia refractory to conventional agents. |
1999-06-18 |
2023-08-12 |
Not clear |
| R D Strous, J K Patel, S Zimmet, A I Gree. Clozapine and paroxetine in the treatment of schizophrenia with obsessive-compulsive features. The American journal of psychiatry. vol 156. issue 6. 1999-06-16. PMID:10360153. |
clozapine and paroxetine in the treatment of schizophrenia with obsessive-compulsive features. |
1999-06-16 |
2023-08-12 |
Not clear |
| M A Lee, K Jayathilake, H Y Meltze. A comparison of the effect of clozapine with typical neuroleptics on cognitive function in neuroleptic-responsive schizophrenia. Schizophrenia research. vol 37. issue 1. 1999-06-10. PMID:10227103. |
a comparison of the effect of clozapine with typical neuroleptics on cognitive function in neuroleptic-responsive schizophrenia. |
1999-06-10 |
2023-08-12 |
Not clear |
| M A Lee, K Jayathilake, H Y Meltze. A comparison of the effect of clozapine with typical neuroleptics on cognitive function in neuroleptic-responsive schizophrenia. Schizophrenia research. vol 37. issue 1. 1999-06-10. PMID:10227103. |
clozapine has been reported to improve selected aspects of cognitive function in neuroleptic-resistant schizophrenia. |
1999-06-10 |
2023-08-12 |
Not clear |
| M A Lee, K Jayathilake, H Y Meltze. A comparison of the effect of clozapine with typical neuroleptics on cognitive function in neuroleptic-responsive schizophrenia. Schizophrenia research. vol 37. issue 1. 1999-06-10. PMID:10227103. |
in this study, we report the first direct comparison of the effect of clozapine and typical neuroleptic drugs on cognitive function in neuroleptic-responsive schizophrenia. |
1999-06-10 |
2023-08-12 |
Not clear |
| M A Lee, K Jayathilake, H Y Meltze. A comparison of the effect of clozapine with typical neuroleptics on cognitive function in neuroleptic-responsive schizophrenia. Schizophrenia research. vol 37. issue 1. 1999-06-10. PMID:10227103. |
sixty-four patients with recent onset, neuroleptic-responsive schizophrenia or schizoaffective disorder were randomly assigned to either clozapine (n = 35) or typical neuroleptics (n = 29) and followed for 12 months. |
1999-06-10 |
2023-08-12 |
Not clear |
| M A Lee, K Jayathilake, H Y Meltze. A comparison of the effect of clozapine with typical neuroleptics on cognitive function in neuroleptic-responsive schizophrenia. Schizophrenia research. vol 37. issue 1. 1999-06-10. PMID:10227103. |
these results suggest that clozapine is superior to typical neuroleptics in improving specific types of cognitive function in recent onset, neuroleptic-responsive schizophrenia. |
1999-06-10 |
2023-08-12 |
Not clear |
| R Rosenheck, J Cramer, E Allan, J Erdos, L K Frisman, W Xu, J Thomas, W Henderson, D Charne. Cost-effectiveness of clozapine in patients with high and low levels of hospital use. Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia. Archives of general psychiatry. vol 56. issue 6. 1999-06-09. PMID:10359474. |
department of veterans affairs cooperative study group on clozapine in refractory schizophrenia. |
1999-06-09 |
2023-08-12 |
Not clear |